Search results for "Precontrast"

showing 5 items of 5 documents

Dynamic contrast-enhanced myocardial perfusion imaging using saturation-prepared TrueFISP.

2002

Purpose To develop and test a saturation-recovery TrueFISP (SR-TrueFISP) pulse sequence for first-pass myocardial perfusion imaging. Materials and Methods First-pass magnetic resonance imaging (MRI) of Gd-DTPA (2 mL) kinetics in the heart was performed using an SR-TrueFISP pulse sequence (TR/TE/α = 2.6 msec/1.4 msec/55°) with saturation preparation TD = 30 msec before the TrueFISP readout. Measurements were also performed with a conventional saturation-recovery TurboFLASH (SRTF) pulse sequence for comparison. Results SR-TrueFISP images were of excellent quality and demonstrated contrast agent wash-in more clearly than SRTF images. The signal increase in myocardium was higher in SR-TrueFISP …

AdultGadolinium DTPAMaterials scienceImage qualityContrast MediaImage processingStatistics NonparametricMyocardial perfusion imagingNuclear magnetic resonancePrecontrastCoronary CirculationmedicineImage Processing Computer-AssistedHumansRadiology Nuclear Medicine and imagingImage resolutionmedicine.diagnostic_testbusiness.industryPhantoms ImagingMicrocirculationMagnetic resonance imagingPulse sequenceMagnetic Resonance ImagingNuclear medicinebusinessPerfusionJournal of magnetic resonance imaging : JMRI
researchProduct

Bolus-enhanced renal spiral CT: technique, diagnostic value and drawbacks

1994

Abstract In addition to pre- and postcontrast renal CT scans, early bolus-enhanced spiral scans during demarcation of the corticomedullary junction were acquired in 85 patients. The diagnostic value and drawbacks of the three imaging series in the evaluation of renal disease were assessed. Renal calcifications and calculus disease detected at precontrast scans (18%) were obscured after contrast administration and excretion in most cases. In the detection of renal lesions bolus-enhanced spiral CT and delayed postcontrast scans had an identical diagnostic yield (94%). Bolus-enhanced spiral CT was superior in the assessment of lesion vascularity and vascular anatomy as well as opacification of…

AdultMalemedicine.medical_specialtyKidney CortexMedullary cavityKidneyRenal Artery Obstructionurologic and male genital diseasesRenal VeinsLesionKidney CalculiRenal ArteryBolus (medicine)VascularityPrecontrastmedicineHumansKidney PelvisRadiology Nuclear Medicine and imagingSpiral ctCarcinoma Renal CellAgedAged 80 and overKidney MedullaKidneybusiness.industryThrombosisGeneral MedicineKidney Diseases CysticMiddle AgedKidney NeoplasmsIopamidolRadiographic Image Enhancementmedicine.anatomical_structureFemaleKidney DiseasesRadiologymedicine.symptomTomography X-Ray ComputedbusinessRenal pelvisFollow-Up StudiesEuropean Journal of Radiology
researchProduct

Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions : results of a mu…

2008

The purpose of this phase III clinical trial was to compare two different extracellular contrast agents, 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine, for magnetic resonance imaging (MRI) in patients with known or suspected focal renal lesions. Using a multicenter, single-blind, interindividual, randomized study design, both contrast agents were compared in a total of 471 patients regarding their diagnostic accuracy, sensitivity, and specificity to correctly classify focal lesions of the kidney. To test for noninferiority the diagnostic accuracy rates for both contrast agents were compared with CT results based on a blinded reading. The average diagnostic accuracy across the three bli…

Gadobutrol; Gadopentate dimeglumine; Renal lesions; MRI; Diagnostic differentiation; NoninferiorityGadolinium DTPAMalemedicine.medical_specialtyContrast MediaRenal lesionsSensitivity and SpecificityGadobutrollaw.inventionGadobutrolPrecontrastRandomized controlled trialmagnetic resonance contrast medialawmedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingSingle-Blind Methodddc:610Neuroradiologymedicine.diagnostic_testbusiness.industryDiagnostic differentiationUltrasoundReproducibility of ResultsMagnetic resonance imagingInterventional radiologyGeneral MedicineNoninferiorityMiddle AgedImage EnhancementMagnetic Resonance ImagingKidney NeoplasmsClinical trialEuropeRadiology Nuclear Medicine and imagingFemaleGadopentate dimeglumineRadiologybusinessNuclear medicinemedicine.drugMRI
researchProduct

Hepatic enhancement in cirrhosis in the portal venous phase: what are the differences between gadoxetate disodium and gadobenate dimeglumine?

2020

Purpose: To compare the level of parenchymal and portal venous enhancement in the portal venous phase (PVP) in cirrhotic patients undergoing gadoxetate disodium- and gadobenate dimeglumine-enhanced MRI. Methods: In this retrospective study, 84 cirrhotic patients (mean age ± SD: 66 ± 13 years) who underwent contrast-enhanced MRI with both gadoxetate disodium and gadobenate dimeglumine between 2012 and 2018 were included. Two readers measured signal intensities of hepatic parenchyma, portal vein and psoas muscle on precontrast and PVP. Relative enhancement (RE), image contrast, and portal vein-to-liver contrast difference were calculated. Intraindividual differences were compared with the Wil…

Gadolinium DTPALiver Cirrhosismedicine.medical_specialtyCirrhosisUrologyPortal veinContrast MediaPortal venous phase030218 nuclear medicine & medical imagingGadoxetate Disodium03 medical and health sciences0302 clinical medicinePrecontrastMeglumineInternal medicineGadobenate dimegluminemedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingGADOBENATE DIMEGLUMINEAgedRetrospective StudiesCirrhosis Portal vein Gadobenate dimeglumine Gadoxetate disodium Hepatic parenchymaHepatic parenchymaRadiological and Ultrasound Technologybusiness.industryGastroenterologyHepatologyMiddle Agedmedicine.diseaseImage EnhancementMagnetic Resonance ImagingCirrhosisHepatic parenchyma030220 oncology & carcinogenesisPortal veinGadoxetate disodiumNuclear medicinebusiness
researchProduct

Qualitative and quantitative evaluation of solitary thyroid nodules with contrast-enhanced ultrasound: initial results

2005

To assess the feasibility of contrast-enhanced ultrasound (CEUS) of the thyroid gland and to evaluate the potential of this method for characterising solitary thyroid nodules.18 patients affected by solitary thyroid nodules (size range: 0.6 to 3.6 cm; mean: 1.8 cm) confirmed by surgery (nine papillary carcinomas, four follicular carcinomas, three hyperplasias, one follicular adenoma and one Plummer’s adenoma) underwent pulse inversion US at low M.I. (0.06 to 0.08) after i.v. injection of a 2.4-mL bolus of SonoVue. Baseline echogenicity and the dynamic enhancement pattern of each nodule, in comparison with adjacent thyroid parenchyma, were assessed. Signal intensity values on grey-scale imag…

Thyroid nodulesAdultMalemedicine.medical_specialtyAdenomamedicine.medical_treatmentSulfur HexafluorideContrast MediaDiagnosis DifferentialPrecontrastImage Interpretation Computer-AssistedmedicineHumansRadiology Nuclear Medicine and imagingThyroid NoduleUltrasonography Doppler ColorPhospholipidsAgedRetrospective Studiesbusiness.industryThyroidUltrasoundThyroidectomyEchogenicityGeneral MedicineMiddle Agedmedicine.diseaseContrast agent Thyroid Ultrasoundmedicine.anatomical_structureThyroidectomyFeasibility StudiesFemaleRadiologybusinessContrast-enhanced ultrasound
researchProduct